期刊文献+

黄芪、全蝎、红花、丹参、葛根混合剂抑制自发性高血压大鼠阻力血管肥厚 被引量:3

The Effect of Naoxintong on the Resistance Vessels Hypertrophy in Spontaneously Hypertensive Rats
下载PDF
导出
摘要 目的观察黄芪、全蝎、红花、丹参、葛根混合剂(脑心通)对自发性高血压大鼠(SHR)阻力血管结构和血压的影响。方法选择12周龄雄性 SHR 大鼠(二级)32只,随机分成4组,脑心通大剂量组[1.5 g/(kg·d)]、脑心通小剂量组[0.5 g/(kg·d)]、氯沙坦组[30 mg/(kg·d)]和 SHR 组(给等量蒸馏水)。另选周龄、性别相匹配的Wistar Kyoto(WKY,给等量蒸馏水)大鼠8只。各组每日灌胃给药。12周后尾袖法测定动脉血压,称质量后处死。HE 染色,计算机图像分析计算血管壁腔比,以观察各组大鼠肠系膜三级动脉的结构变化。结果 1)大、小剂量脑心通治疗后,两组 SBP 均显著低于 SHR 组[脑心通大剂量:(153.6±12.2)比脑心通小剂量:(159.2±5.8)比 SHR:(178.6±12.0)mmHg,P<0.01];大剂量脑心通组 SHR 治疗后 SBP 较治疗前明显降低[(153.6±12.2)比治疗前(163.6±11.8)mmHg,P<0.01],与小剂量组比较能更进一步降低血压(P<0.05)。2)与 SHR 组相比,小剂量脑心通治疗对肠系膜三级动脉血管的管壁面积/管腔面积及管壁厚度/管腔半径比值无影响,而大剂量脑心通可显著降低肠系膜三级动脉血管的管壁面积/管腔面积(W/L:脑心通大剂量:0.29±0.01比脑心通小剂量:0.37±0.06比SHR:0.44±0.04,P<0.01)及管壁厚度/管腔半径(Tw/RI:脑心通大剂量:0.12±0.01比脑心通小剂量:0.17±0.03比 SHR:0.20±0.02,P<0.01)。结论脑心通可剂量依赖地抑制 SHR 大鼠血压的发展,减轻 SHR 阻力血管的肥厚。 Objective To observe the effect of Naoxintong (NXT), one of Chinese traditional herbal composition, on the resistance vessels hypertrophy in spontaneously hypertensive rats ( SHR). Methods Thirty-two twelve-week-old male SHR were randomized to high-dose NXT treated group [NH group, 1.5 g/( kg · d), n= 8], low-dose NXT treated group [NL group, 0. 5 g/(kg · d), n=8-1, losartan treated group [LOS group, 30 mg/(kg · d), n =8-1 and distilled water control (SHR group, n=8). Wistar-Kyoto rats(WKY group, n=8) were served as normal control. Naoxintong were administered for 12 weeks by gavage in mixture with 2 mL distilled water, SHR and WKY control were received the same amount of distilled water. Systolic blood pressure(SBP) was measured by the tail-cuff method. Wall-to-lumen area ratios of mesenteric arteries ( 3th branch) were calculated. Results 1 ) After 12 weeks treatment with high-dose and low-dose NXT, SBP in both groups was markedly lower than that in SHR control group (NH : 153.6 ± 12. 2 vs NL: 159.2 ± 5.8 vs SHR: 178.6 ± 12.0 mmHg, P〈0.01). High-dose NXT slightly, but statistically significantly decreased SBP( 153.6±12. 2 vs baseline: 163.6±11.8 mmHg, P〈0.01 ). 2 ) Wall-to-lumen area ratio( W/L) and the thickness of the wall to the radius of the lumen( Tw/RI) in mesenteric arteries ( 3th branch) were significantly reduced in high-dose NXT group than in SHR group( W/L, NH:0.29±0.01 vs NL:0.37±0. 06 vs SHR:0.44+0.04,P〈0.01; Tw/RI, NH:0.12±0.01 vs NL:0. 17±0.03 vs SHR: 0.20± 0.02, P〈0.01). Conclusion NXT attenuates the resistance vessels hypertrophy in SHR, which may be the mechanism by which Naoxintong prevents the progression of arterial blood pressure.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2008年第4期322-325,共4页 Chinese Journal of Hypertension
关键词 脑心通 自发性高血压大鼠 阻力血管 高血压 Naoxintong Spontaneously hypertensive rats Resistance vessels Hypertension
  • 相关文献

参考文献4

二级参考文献14

  • 1陈达光,晋学庆,陈松苍,王华军.卡托普利改善血管结构与降压效果的关系[J].中华医学杂志,1995,75(6):355-359. 被引量:9
  • 2肖文良 刘哲 赵维江 等.通心络胶囊对不稳定性心绞痛血管内皮细胞保护作用及疗效[J].中国新药杂志,1987,7:26-29.
  • 3贾真 顾复生 吴以岭.通心络胶囊对血管内皮功能的影响中医络病学说与心脑血管病代表方药通心络胶囊实验与临床研究[M].北京:中国科学技术出版社,2001.1-5.
  • 4Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats[J]. Circ Res, 1977,41: 19-26.
  • 5Follow B. Cardiovascular structural adaption:its role in the intitiation and maintenance of primary hypertension[J]. Clin Sci Mol Med, 1987,55:3-8.
  • 6Follow B. Extrinic mechanism of vascular growth[J]. J Clin Hypertens, 1987,3: 328-336.
  • 7Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension,2001,38(part2):581~587.
  • 8Schiffrin EL, Park JB, Intengan HD, et al. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist Losartan. Circulation,2000,101(14):1 653~1 659.
  • 9Touyz RM, He G, El Mabrouk M, et al. Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats. J Hypertens, 2001,19(3Pt2): 553~559.
  • 10Nunez E,Hosoya K, Susic D,et al. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR. J Hypertens,1997,29(1Pt2):519~524.

共引文献19

同被引文献48

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部